Robeco Institutional Asset Management B.V. Sells 72,302 Shares of Centene Co. (NYSE:CNC)

Robeco Institutional Asset Management B.V. trimmed its holdings in shares of Centene Co. (NYSE:CNC) by 7.4% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 907,692 shares of the company’s stock after selling 72,302 shares during the quarter. Robeco Institutional Asset Management B.V. owned about 0.18% of Centene worth $54,988,000 at the end of the most recent quarter.

Several other institutional investors also recently bought and sold shares of CNC. Harris Associates L P raised its stake in shares of Centene by 5.7% in the 3rd quarter. Harris Associates L P now owns 26,314,183 shares of the company’s stock valued at $1,980,932,000 after acquiring an additional 1,420,825 shares in the last quarter. State Street Corp grew its holdings in Centene by 0.5% during the third quarter. State Street Corp now owns 23,468,159 shares of the company’s stock valued at $1,766,683,000 after purchasing an additional 111,654 shares during the last quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC lifted its stake in shares of Centene by 3.5% in the third quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 5,768,534 shares of the company’s stock worth $434,255,000 after buying an additional 194,566 shares during the last quarter. Hotchkis & Wiley Capital Management LLC boosted its holdings in shares of Centene by 15.4% during the 3rd quarter. Hotchkis & Wiley Capital Management LLC now owns 3,203,049 shares of the company’s stock worth $241,126,000 after buying an additional 428,100 shares during the period. Finally, Assenagon Asset Management S.A. grew its stake in Centene by 693.5% in the 4th quarter. Assenagon Asset Management S.A. now owns 1,705,936 shares of the company’s stock valued at $103,346,000 after buying an additional 1,490,935 shares during the last quarter. 93.63% of the stock is currently owned by institutional investors.

Wall Street Analysts Forecast Growth

CNC has been the subject of a number of recent analyst reports. Barclays upped their price target on shares of Centene from $91.00 to $93.00 and gave the company an “overweight” rating in a report on Friday, December 13th. UBS Group upgraded Centene from a “neutral” rating to a “buy” rating and increased their target price for the company from $79.00 to $80.00 in a research note on Friday, December 13th. Oppenheimer dropped their price target on Centene from $95.00 to $85.00 and set an “outperform” rating on the stock in a research report on Friday, December 13th. StockNews.com raised Centene from a “buy” rating to a “strong-buy” rating in a research report on Monday. Finally, Stephens dropped their target price on shares of Centene from $75.00 to $73.00 and set an “equal weight” rating on the stock in a research report on Friday, December 13th. One investment analyst has rated the stock with a sell rating, four have issued a hold rating, nine have given a buy rating and one has issued a strong buy rating to the stock. Based on data from MarketBeat, the stock has an average rating of “Moderate Buy” and a consensus target price of $80.92.

Centene Stock Performance

NYSE:CNC opened at $63.89 on Thursday. The company has a quick ratio of 1.10, a current ratio of 1.10 and a debt-to-equity ratio of 0.64. The firm has a 50-day moving average price of $60.91 and a 200 day moving average price of $67.21. The firm has a market capitalization of $32.26 billion, a PE ratio of 11.09, a price-to-earnings-growth ratio of 0.85 and a beta of 0.45. Centene Co. has a 12-month low of $55.03 and a 12-month high of $81.42.

Insider Buying and Selling

In other news, CEO Sarah London acquired 4,117 shares of the firm’s stock in a transaction on Friday, November 8th. The shares were purchased at an average cost of $60.80 per share, with a total value of $250,313.60. Following the completion of the purchase, the chief executive officer now owns 667,229 shares of the company’s stock, valued at $40,567,523.20. This represents a 0.62 % increase in their ownership of the stock. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, CFO Andrew Lynn Asher bought 17,200 shares of the business’s stock in a transaction dated Wednesday, November 13th. The stock was purchased at an average price of $58.14 per share, with a total value of $1,000,008.00. Following the purchase, the chief financial officer now directly owns 486,847 shares of the company’s stock, valued at $28,305,284.58. The trade was a 3.66 % increase in their position. The disclosure for this purchase can be found here. Insiders purchased 45,010 shares of company stock worth $2,660,276 in the last 90 days. 0.33% of the stock is owned by company insiders.

Centene Company Profile

Centene Corporation operates as a healthcare enterprise that provides programs and services to under-insured and uninsured families, commercial organizations, and military families in the United States. The company operates through Medicaid, Medicare, Commercial, and Other segments. The Medicaid segment offers health plan coverage, including medicaid expansion, aged, blind, disabled, children’s health insurance program, foster care, medicare-medicaid plans, long-term services and support.